Giá Jenscare Scientific Co., Ltd. (09877.HK)

Jenscare Scientific Co., Ltd. is a holding company, which engages in the development and sale of transcatheter aortic valve systems. The company is headquartered in Ningbo, Zhejiang and currently employs 174 full-time employees. The company went IPO on 2022-10-10. The firm develops a series of treatment solutions targeting different types of structural heart diseases. The firm's products and pipelines mainly include LuX-Valve, LuX-Valve Plus, Ken-Valve, JensClip, JensRelive, MicroFlux and SimuLock. LuX-Valve is the transcatheter tricuspid valve replacement system designed to treat patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is the transcatheter aortic valve replacement system designed to treat patients with severe aortic regurgitation or combined with aortic stenosis.